PEROXISOMES
Zydus Saroglitazar shows positive Phase 3 results in rare liver disease PBC, US filing planned in 2026Zydus Therapeutics reveals encouraging outcomes from Saroglitazar's clinical trial. The drug targets Primary Biliary Cholangitis. The EPICS...
Scientists develop new class of antiviral drugs to fight against Covid infectionScientists from the University of Alberta in Canada have made a significant breakthrough in the fight against COVID-19 by discovering a new...
- Load More